阿拉伯语国际体育锻炼问卷测量糖尿病患者中等强度到高强度体育锻炼的有效性
IF 4.6
Q2 MATERIALS SCIENCE, BIOMATERIALS
引用次数: 0
摘要
目的：本横断面研究旨在比较阿拉伯语版国际体力活动问卷（IPAQ）测量的糖尿病患者中强度体力活动（MVPA）与加速度计测量的中强度体力活动：从 2020 年到 2022 年，对科威特≥ 18 岁的 1 型或 2 型糖尿病患者的体力活动进行了测量。使用阿拉伯语版的 IPAQ 对自我报告的 MVPA 进行了为期 7 天的测量。在同一 7 天内，使用腕戴式加速度计对 MVPA 进行客观测量。IPAQ MVPA 的计算包括和不包括步行体力活动。MVPA 测量结果通过一致性极限法、皮尔逊相关性和一致性相关性进行比较：我们招募了 240 名 1 型糖尿病患者和 343 名 2 型糖尿病患者参与研究。在 1 型糖尿病患者中，IPAQ MVPA 与包括步行体力活动（rho = - 0.011 (- 0.038, 0.017)，p = 0.444）和不包括步行体力活动（rho = - 0.001 (- 0.067, 0.065)，p = 0.978）之间不存在协整相关性。如果包括步行，IPAQ 测量的 MVPA 比加速度计测量的 MVPA 高 43.3（- 85.6，172.2）分钟/天；如果不包括步行，则 MVPA 高 8.88（- 60.4，78.2）分钟/天。在 2 型糖尿病患者中，IPAQ MVPA 与包括步行（rho = 0.038 (0.02, 0.06)，p <0.001）和不包括步行（rho = 0.34 (0.27, 0.41)，p <0.001）的体力活动之间存在显著的正相关性。在包括步行的情况下，IPAQ测量的MVPA比加速度计测量的MVPA高62.3（95% CI - 61.5至186.0）分钟/天；在不包括步行的情况下，IPAQ测量的MVPA比加速度计测量的MVPA高4.0（95% CI - 34.1至42.0）分钟/天：结论：对于1型或2型糖尿病患者，在使用阿拉伯语版IPAQ测量MVPA时应谨慎。 关键词：代谢性疾病；活动；阿拉伯语；验证本文章由计算机程序翻译，如有差异，请以英文原文为准。
Validity of the Arabic International Physical Activity Questionnaire to Measure Moderate-to-Vigorous Physical Activity in People with Diabetes
Purpose: The aim of this cross-sectional study was to compare the Arabic version of International Physical Activity Questionnaire (IPAQ) measured moderate-to-vigorous physical activity (MVPA) with accelerometer-measured MVPA in people with diabetes.
Methods: From 2020 to 2022 physical activity was measured people ≥ 18 years with type 1 or type 2 diabetes in Kuwait. Self-reported MVPA was measured over 7 days with the Arabic version of the IPAQ. During the same 7-day period wrist worn accelerometers were used to objectively measure MVPA. IPAQ MVPA was calculated both including and excluding walking physical activity. MVPA measures were compared by limits of agreement approach, Pearson correlations and concordance correlations.
Results: We recruited 240 participants with type 1 diabetes and 343 participants with type 2 diabetes for the study. In people with type 1 diabetes, there were no concordance correlations between IPAQ MVPA, both including (rho = − 0.011 (− 0.038, 0.017), p = 0.444) and excluding (rho = − 0.001 (− 0.067, 0.065), p = 0.978) walking physical activity. MVPA measured by IPAQ was 43.3(− 85.6, 172.2) min/day higher than accelerometer-measured MVPA, when including walking, and 8.88(− 60.4, 78.2) min/day higher, when excluding walking. In people with type 2 diabetes, there were significant positive concordance correlations between IPAQ MVPA, both including (rho = 0.038 (0.02, 0.06), p < 0.001) and excluding (rho = 0.34 (0.27, 0.41), p < 0.001) walking physical activity. MVPA measured by IPAQ was 62.3 (95% CI − 61.5 to 186.0) min/day higher than accelerometer-measured MVPA, when including walking, and 4.0 (95% CI − 34.1 to 42.0) min/day higher, when excluding walking.
Conclusion: In people with type 1 or type 2 diabetes, caution should be exercised when using the Arabic version of the IPAQ to measure MVPA.
Keywords: metabolic disease, activity, Arab, validation
Methods: From 2020 to 2022 physical activity was measured people ≥ 18 years with type 1 or type 2 diabetes in Kuwait. Self-reported MVPA was measured over 7 days with the Arabic version of the IPAQ. During the same 7-day period wrist worn accelerometers were used to objectively measure MVPA. IPAQ MVPA was calculated both including and excluding walking physical activity. MVPA measures were compared by limits of agreement approach, Pearson correlations and concordance correlations.
Results: We recruited 240 participants with type 1 diabetes and 343 participants with type 2 diabetes for the study. In people with type 1 diabetes, there were no concordance correlations between IPAQ MVPA, both including (rho = − 0.011 (− 0.038, 0.017), p = 0.444) and excluding (rho = − 0.001 (− 0.067, 0.065), p = 0.978) walking physical activity. MVPA measured by IPAQ was 43.3(− 85.6, 172.2) min/day higher than accelerometer-measured MVPA, when including walking, and 8.88(− 60.4, 78.2) min/day higher, when excluding walking. In people with type 2 diabetes, there were significant positive concordance correlations between IPAQ MVPA, both including (rho = 0.038 (0.02, 0.06), p < 0.001) and excluding (rho = 0.34 (0.27, 0.41), p < 0.001) walking physical activity. MVPA measured by IPAQ was 62.3 (95% CI − 61.5 to 186.0) min/day higher than accelerometer-measured MVPA, when including walking, and 4.0 (95% CI − 34.1 to 42.0) min/day higher, when excluding walking.
Conclusion: In people with type 1 or type 2 diabetes, caution should be exercised when using the Arabic version of the IPAQ to measure MVPA.
Keywords: metabolic disease, activity, Arab, validation
求助全文
通过发布文献求助，成功后即可免费获取论文全文。
去求助
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
